E

ESSA Pharma
D

EPIX

1.61000
USD
-0.02
(-1.23%)
Market Closed
Volume
301
EPS
-1
Div Yield
-
P/E
-3
Market Cap
71,465,567
News

Title: ESSA Pharma

Sector: Healthcare
Industry: Biotechnology
ESSA Pharma Inc is a pharmaceutical company. The company is focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.